HR
BHC icon

Hayden Royal’s Bausch Health BHC Stock Holding History

Hayden Royal’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-40,057
Closed -$1.18M – 99
2021
Q2 		$1.18M Hold
40,057
– – 0.65% 35
2021
Q1 		$1.27M Buy
+40,057
New +$1.17M 0.73% 33
2020
Q4 		– Sell
-47,247
Closed -$734K – 474
2020
Q3 		$734K Buy
47,247
+1,895
+4% +$32.6K 0.39% 64
2020
Q2 		$830K Buy
45,352
+3,414
+8% +$60.2K 0.47% 52
2020
Q1 		$650K Sell
41,938
-34,162
-45% -$824K 0.38% 67
2019
Q4 		$2.13M Buy
76,100
+22,825
+43% +$593K 1.08% 21
2019
Q3 		$1.16M Buy
53,275
+1,288
+2% +$29.5K 1.02% 25
2019
Q2 		$1.24M Sell
51,987
-687
-1% -$16.3K 1.32% 13
2019
Q1 		$1.3M Buy
52,674
+14,072
+36% +$336K 1.7% 12
2018
Q4 		$714K Buy
+38,602
New +$918K 0.36% 63

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hayden Royal's BHC Position: Q3 2021 in Review

Hayden Royal sold out of Bausch Health (BHC) in Q3 2021, closing a stake of 40,057 shares — an estimated $1.18M sold.

Hayden Royal first reported a position in BHC in Q4 2018 and held it in 10 quarters. The position peaked at $2.13M in Q4 2019. 346 funds tracked by Wall St. Rank hold BHC as of Q3 2021.

  • Hayden Royal reported no remaining Bausch Health position as of Q3 2021 after selling out during the quarter.
  • Hayden Royal sold 40,057 Bausch Health shares in Q3 2021, an estimated $1.18M.
  • Hayden Royal first reported a position in Bausch Health in Q4 2018 and held it in 10 quarters.
  • Hayden Royal's Bausch Health position peaked at $2.13M in Q4 2019.
  • 346 funds tracked by Wall St. Rank held Bausch Health as of Q3 2021.

Based on Hayden Royal's 13F filing for Q3 2021, filed 15 Nov 2021.